Cell-free metabolic pathway for glucose metabolism with a molecular purge valve
AssigneeThe Regents of the University of California
InventorsJames U. Bowie, Tyler P. Korman, Paul H. Opgenorth
Life of this patent
Estimating the term…
Abstract
Provided is an engineered pathway that can function in a cell-free system, cellular system or a combination thereof to convert a sugar to a chemical or biofuel.
Claims6
A cell-free in vitro metabolic pathway comprising a plurality of enzymatic steps that converts a substrate to acetyl-phosphate, pyruvate, glyceraldehyde-3-phosphate, or acetyl-CoA, wherein the pathway includes an unbalanced production and utilization of a co-factor, the pathway comprising a non-naturally occurring purge valve pathway that recycles the co-factor, wherein the non-naturally occurring purge valve pathway comprises (i) a wild-type enzyme that utilizes NADP+, (ii) a mutant of the wild-type enzyme that utilizes NAD+ and (iii) an NADH oxidase, wherein the wild-type enzyme of (i) is a glucose-6-phosphate dehydrogenase and/or a 6-phosphogluconate dehydrogenase and wherein the pathway comprises pentose phosphate pathway enzymes including glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase,
- wherein (1) the wild-type enzyme of (i) has a sequence that is 95% identical to SEQ ID NO:23 and has glucose-6-phosphate dehydrogenase activity and uses NADP+ as a cofactor and the mutant enzyme of (ii) has a sequence that is 95% identical to SEQ ID NO:24 and has glucose-6-phosphate dehydrogenase activity and uses NAD+ as a cofactor;
- and/or (2) wherein the wild-type enzyme of (i) has a sequence that is 95% identical to SEQ ID N0:27 and has 6-phosphogluconate dehydrogenase activity and uses NADP+ as a cofactor and the mutant enzyme of (ii) has a sequence that is 95% identical to SEQ ID NO:28 and has 6-phosphogluconate dehydrogenase activity and uses NAD+ as a cofactor;
- and
- wherein the NADH oxidase of (iii) has a sequence that is at least 80% identical to SEQ ID NO:18 and has NADH oxidase activity.
A cell-free in vitro pathway for producing acetyl-phosphate from glucose comprising:
- (a) a phosphoketolase (F/Xpk or Xfp);
- (b) a transaldolase (tal);
- (c) a transketolase (tkt);
- (d) a ribose-5phosphate isomerase (Rpi);
- (e) a ribulose-5phospate epimerase (Rpe);
- (f) a triose phosphate isomerase (Tpi);
- (g) a fructose 1,6 bisphosphate aldolase (Fba);
- (h) a glucokinase (Glk);
- (i) a glucose-6-phosphate dehydrogenase (Zwf) having the sequence of SEQ ID NO:23;
- (j) a 6-phosphogluconolactonase (pgl);
- (k) a 6-phosphogluconate dehydrogenase (Gnd) having the sequence of SEQ ID NO:27;
- (I) a phosphoglucoisomerase (pgi);
- (m) a phosphofructokinase (pfk);
- (n) a mutant 6-phosphogluconate (mGnd) having the sequence of SEQ ID NO:28;
- (o) a mutant glucose-tphosphate dehydrogenase (mZwf) having the sequence of SEQ ID NO:24;
- and
- (p) an NADH oxidase.
Dependencies are inferred from the claim text.